World News Insights
1-3 Minute Gist

All Topics Article

Deal Flurry Shows Drug Makers' Swing Toward Specialization

Wall Street Journal Original article ›

Keywords:


Glaxo Novartis deals in 2014 for an asset exchange

04/23/2014

Grouped Articles

Glaxo, Novartis Keep Deal-Making on Target

Wall Street Journal 04/23/2014

Glaxo Exits Cancer Drugs

Wall Street Journal 04/23/2014

Deal Flurry Shows Drug Makers' Swing Toward Specialization

Wall Street Journal 04/23/2014

Novartis chairman Joerg Reinhardt and new R&D- product strategies in 2013-2015

03/22/2014

A review of the portfolio of business in 2013-2014 and a new focus on R&D with a board subcommittee overseeing the effort. Reinhardt is personally heading the effort, and has conversations also with new chairman Franz at Roche in which Novartis has a one third stake.

Grouped Articles

Novartis Chairman Stresses Need for R&D Investment

Wall Street Journal 03/22/2014

Glaxo Exits Cancer Drugs

Wall Street Journal 04/23/2014

Deal Flurry Shows Drug Makers' Swing Toward Specialization

Wall Street Journal 04/23/2014


Support LyrArc

We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.

Support Lyrarc from as small as $1


Copyright © 2006 - 2026 Intelilinks LLC
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us